Effects of concentrated supernatants recovered from Lactobacillus plantarum on Escherichia coli growth and on the viability of a human promyelocytic cell line

Journal of Applied Microbiology

Volumn 106, Issue 4, 2009, Pages 1194-1203

  Puertollano, E ^a   Puertollano, M A ^a,b   Cruz Chamorro, L ^a   De Cienfuegos, G A ^a   Ruiz Bravo, A ^c   De Pablo, M A ^a  

^a UNIVERSITY OF JAÉN   (Spain)

^b CSIC   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Concentrated supernantants; HL 60 cells; Lactic acid bacteria; Lactobacillus plantarum; Probiotics

Indexed keywords

BACILLI; CELL CULTURE; CELL MEMBRANES; CONCENTRATION (PROCESS); LACTIC ACID; SALTS;

CELL LINES; CONCENTRATED SUPERNANTANT; E. COLI; ESCHERICHIA COLI GROWTHS; EUKARYOTIC CELLS; HL-60 CELLS; LACTIC ACID BACTERIA; LACTOBACILLUS PLANTARUM; PROBIOTICS; SUPERNATANTS;

ESCHERICHIA COLI;

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; LACTOBACILLUS PLANTARUM EXTRACT; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOACTIVITY; CENTRIFUGE; GROWTH RATE; HOMINID; INHIBITION; PATHOGEN; PROBIOTICS; VIABILITY;

ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIOSTASIS; CANCER CELL CULTURE; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; ESCHERICHIA COLI; GROWTH INHIBITION; HUMAN; HUMAN CELL; LACTOBACILLUS PLANTARUM; LEUKEMIA CELL; NONHUMAN; PATHOGENIC ESCHERICHIA COLI; PROMYELOCYTIC LEUKEMIA; SUPERNATANT;

EID: 62149111775     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2008.04086.x     Document Type: Article

References (35)

1. Alvarez-Olmos, M.I. Oberhelman, R.A. (2001) Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infect Dis 32, 1567 1576.
2. Baricault, L., Denariaz, G., Houri, J.J., Bouley, C., Sapin, C. Trugnan, G. (1995) Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 26, 245 252.
3. Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L. Hudault, S. (1997) The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol 63, 2747 2753.
4. Biffi, A., Coradini, D., Larsen, R., Riva, L. Di Fronzo, G. (1997) Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 28, 93 99.
5. Bujalance, C., Moreno, E., Jimenez-Valera, A. Ruiz-Bravo, A. (2007) A probiotics strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice. Int J Food Microbiol 113, 28 34.
6. Charteris, W.P., Kelly, P.M., Morelli, L. Collins, J.K. (1998) Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot 61, 1636 1643.
7. Chou, L.S. Weimer, B. (1999) Isolation and characterization of acid- and bile-tolerant isolates from strains of Lactobacillus acidophilus. J Dairy Sci 82, 23 31.
8. Cross, M.L. (2002) Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunol Med Microbiol 34, 245 253.
9. Cruz-Chamorro, L., Puertollano, M.A., Puertollano, E., Alvarez de Cienfuegos, G. de Pablo, M.A. (2006) In vitro biological activities of magainin alone or in combination with nisin. Peptides 27, 1201 1209.
10. Decker, T. Lohmann-Matthes, M.L. (1988) A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity. J Immunol Methods 115, 61 69.
11. FAO/WHO (2001). Evaluation of Health and Nutritional Properties of Probiotics in Food, Including Powder Milk with Live Lactic Acid Bacteria. Food and Agriculture. Organization of the United Nations and World Health Organization Expert Consultation Report. http://www.who.int/foodsafety/ publications/fs-management/en/probiotics.pdf.
12. Fichera, G.A. Giese, G. (1994) Non-immunoimmunologically-mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumour cell lines. Cancer Lett 85, 93 103.
13. Fooks, L.J., Fuller, R. Gibson, G.R. (1999) Prebiotics, probiotics and human gut microbiology. Int Dairy J 9, 53 61.
14. Gill, H.S. Rutherfurd, K.J. (2001) Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br J Nutr 86, 285 289.
15. Halper, J., Leshin, L.S., Lewis, S.J. Li, W.I. (2003) Wound healing and angiogenic properties of supernatants from Lactobacillus cultures. Exp Biol Med 228, 1329 1337.
16. Hirayama, K. Rafter, J. (2000) The role of probiotic bacteria in cancer prevention. Microbes Infect 2, 681 686.
17. Ishida-Fujii, K., Sato, R., Goto, S., Yang, X.P., Kuboki, H., Hirano, S. Sato, M. (2007) Prevention of pathogenic Escherichia coli infection in mice and stimulation of macrophage activation in rats by an oral administration of probiotic Lactobacillus casei I-5. Biosci Biotechnol Biochem 71, 866 873.
18. Lebaron, P., Catala, P. Parthuisot, N. (1998) Effectiveness of SYTOX Green stain for bacterial viability assessment. Appl Environ Microbiol 6, 2697 2700.
19. LeBlanc, J.G., Matar, C., Valdez, J.C., LeBlanc, J. Perdigon, G. (2002) Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J Dairy Sci 85, 2733 2742.
20. Li, W.I., Brackett, B.G. Halper, J. (2005) Culture supernatant of Lactobacillus acidophilus stimulates proliferation of embryonic cells. Exp Biol Med 230, 494 500.
21. Maldonado-Galdeano, C., de Moreno de Leblanc, A., Vinderola, G., Bibas Monet, M.E. Perdigon, G. (2007) Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol 14, 485 492.
22. Murosaki, S., Muroyama, K., Yamamoto, Y. Yoshikai, Y. (2000) Antitumor effect of heat-killed Lactobacillus plantarum L-137 through restoration of impaired interleukin-12 production in tumor-bearing mice. Cancer Immunol Immunother 49, 157 164.
23. Niku-Paavola, M.L., Laitila, A., Mattila-Sandholm, T. Haikara, A. (1999) New types of antimicrobial compounds produced by Lactobacillus plantarum. J Appl Microbiol 86, 29 35.
24. Ogawa, M., Shimizu, K., Nomoto, K., Takahashi, M., Watanuki, M., Tanaka, R., Tanaka, T., Hamabata, T. et al. (2001) Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect Immun 69, 1101 1108.
25. Park, C.B., Kim, H.S. Kim, S.C. (1998) Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem Biophys Res Commun 244, 253 257.
26. Park, J.H., Seok, S.H., Cho, S.A., Baek, M.W., Lee, H.Y., Kim, D.J., Chung, M.J., Kim, S.D. et al. (2005) Antimicrobial effects of lactic acid producing bacteria culture condensate mixture (LCCM) against Salmonella enteritidis. Int J Food Microbiol 101, 111 117.
27. Parvez, S., Malik, K.A., Ah Kang, S. Kim, H.Y. (2006) Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 100, 1171 1185.
28. Puertollano, E., Puertollano, M.A., Cruz-Chamorro, L., Alvarez de Cienfuegos, G., Ruiz-Bravo, A. de Pablo, M.A. (2008) Orally administered Lactobacillus plantarum reduces pro-inflammatory interleukin secretion in sera from Listeria monocytogenes infected mice. Br J Nutr 99, 819 825.
29. Roth, B.L., Poot, M., Yue, S.T. Millard, P.J. (1997) Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain. Appl Environ Microbiol 63, 2421 2431.
30. Servin, A.L. (2004) Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28, 405 440.
31. Shellhaas, J.L. Zuckerman, S.H. (1995) In vitro detection of apoptotic stimuli by use of the HL-60 myeloid leukemic cell line. Clin Diagn Lab Immunol 2, 598 603.
32. Shu, Q. Gill, H.S. (2002) Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 34, 59 64.
33. Vandenbergh, P.A. (1993) Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev 12, 221 237.
34. Yan, F. Polk, D.B. (2002) Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 277, 50959 50965.
35. Yan, F., Cao, H., Cover, T.L., Whitehead, R., Washington, M.K. Polk, D.B. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562 575.